Crimean Congo-Haemorrhagic Fever treated with oral ribavirin
- 1 August 1995
- journal article
- case report
- Published by Elsevier BV in The Lancet
- Vol. 346 (8973), 472-475
- https://doi.org/10.1016/s0140-6736(95)91323-8
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infectionAntiviral Research, 1993
- Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal SyndromeThe Journal of Infectious Diseases, 1991
- Inhibition of Crimean-Congo Hemorrhagic Fever Viral Infectivity Yields in Vitro by RibavirinThe American Journal of Tropical Medicine and Hygiene, 1989
- Antibody Response in Crimean-Congo Hemorrhagic FeverClinical Infectious Diseases, 1989
- The Clinical Pathology of Crimean-Congo Hemorrhagic FeverClinical Infectious Diseases, 1989
- Prospects for Treatment of Viral Hemorrhagic Fevers with Ribavirin, a Broad-Spectrum Antiviral DrugClinical Infectious Diseases, 1989
- Lassa FeverNew England Journal of Medicine, 1986
- CONGO/CRIMEAN HÆMORRHAGIC FEVER IN DUBAIThe Lancet, 1980
- Nosocomial Outbrak of Viral Hemorrhagic Fever Caused by Crimean Hemorrhagic Fever-Congo Virus in Pakistan, January 1976 *The American Journal of Tropical Medicine and Hygiene, 1980
- Review Article 1: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa23Journal of Medical Entomology, 1979